Depending on the type of MDS or AML, NSCs are enriched in the CD34+CD38− or CD34+CD38+ fraction of the clone, and give rise to additional NSCs as well as (more mature) blast cells that lack engraftment potential [9,10]. This evidence concerns the gene CD38 and myelodysplastic syndrome.